Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

OriGene Pays $16 Million for Antibody Maker SDIX

publication date: Apr 9, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OriGene Technologies acquired the assets of SDIX for $16 million, adding SDIX’s signature platform, Advanced Genomic Antibody Technology™, to OriGene’s collection of research tools, notably its cDNA library. OriGene has global operations, including three facilities in China, which will give greater visibility to SDIX products. Two weeks ago, OriGene raised $21.3 million from China-focused investors in a C round. More details....

Stock Symbol: (NSDQ: SDIX)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors